Minor
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
Trial completed
Also in this update: Final enrollment: 7 participants (planned 18); Primary completion date changed from estimate of Aug 2026 to Jun 25, 2026
Regeneration Biomedical, Inc.Phase 1 NCT05667649 Registry history of NCT05667649 on ClinicalTrials.gov (opens the registry)